A New EBV Related Technologies of T Cells in Treating Malignant Tumors and Clinical Application
NCT02980315
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
UNKNOWN
Status
20
Enrollment
OTHER
Sponsor class
Conditions
Nasopharyngeal Neoplasms
Interventions
OTHER:
CAR-T cells
Sponsor
The Second Hospital of Nanjing Medical University